Interpretation and conclusion: Expressions of CD34 and CD10 are adverse prognostic factors in AYA pre-B-ALL patients and the presence of these antigens influences the clinical outcome of these patients. This evidence concerns the gene CD34 and acute lymphoblastic leukemia.